iSpecimen Inc. (ISPC)
NASDAQ: ISPC · Real-Time Price · USD
1.630
-0.010 (-0.61%)
Aug 27, 2026, 1:25 PM EDT - Market open
iSpecimen Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.47 | 1.93 | 9.29 | 9.93 | 10.4 | 11.14 | |
Revenue Growth | -92.11% | -79.24% | -6.42% | -4.56% | -6.58% | 36.06% |
Cost of Revenue | 0.97 | 1.9 | 5.3 | 4.82 | 4.76 | 5.25 |
Gross Profit | -0.5 | 0.02 | 3.99 | 5.11 | 5.65 | 5.89 |
Selling, General & Admin | 7.28 | 6.84 | 13.19 | 12.71 | 13.18 | 9.97 |
Research & Development | 1.63 | 2.16 | 3.53 | 3.57 | 2.66 | 1.84 |
Operating Expenses | 8.91 | 9 | 16.72 | 16.28 | 15.83 | 11.81 |
Operating Income | -9.42 | -8.98 | -12.73 | -11.17 | -10.19 | -5.93 |
Interest Expense | -0 | -0.01 | -0.22 | -0.23 | -0.24 | -2.1 |
Interest & Investment Income | 0 | 0 | 0.04 | 0.34 | 0.17 | 0.01 |
Other Non Operating Income (Expenses) | -2 | -1.5 | 0.41 | -0.04 | 0.01 | 1.27 |
EBT Excluding Unusual Items | -11.42 | -10.49 | -12.5 | -11.1 | -10.25 | -6.75 |
Other Unusual Items | - | - | - | - | - | -2.21 |
Pretax Income | -11.42 | -10.49 | -12.5 | -11.1 | -10.25 | -8.96 |
Net Income | -11.42 | -10.49 | -12.5 | -11.1 | -10.25 | -8.96 |
Net Income to Common | -11.42 | -10.49 | -12.5 | -11.1 | -10.25 | -8.96 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 1 | 0 | 0 | 0 | 0 | - |
Shares Outstanding (Diluted) | 1 | 0 | 0 | 0 | 0 | - |
Shares Change | 1153.73% | 547.47% | 57.24% | 2.23% | - | - |
EPS (Basic) | -21.95 | -91.15 | -703.27 | -982.08 | -926.81 | - |
EPS (Diluted) | -21.95 | -91.15 | -703.27 | -982.08 | -928.00 | - |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -7 | -4.24 | -8.32 | -5.83 | -6.03 | -10.67 |
Free Cash Flow Per Share | -13.46 | -36.86 | -468.19 | -515.58 | -545.75 | - |
Gross Margin | -108.26% | 1.25% | 42.93% | 51.45% | 54.27% | 52.86% |
Operating Margin | -2020.04% | -465.42% | -136.99% | -112.50% | -97.92% | -53.21% |
Profit Margin | -2449.04% | -543.68% | -134.51% | -111.80% | -98.50% | -80.48% |
Free Cash Flow Margin | -1502.03% | -219.86% | -89.55% | -58.69% | -58.00% | -95.83% |
EBITDA | -9.28 | -8.72 | -12.47 | -11 | -10.16 | -5.88 |
EBITDA Margin | - | - | -134.22% | -110.82% | -97.71% | -52.80% |
D&A For EBITDA | 0.13 | 0.26 | 0.26 | 0.17 | 0.02 | 0.05 |
EBIT | -9.42 | -8.98 | -12.73 | -11.17 | -10.19 | -5.93 |
EBIT Margin | - | - | -136.99% | -112.50% | -97.92% | -53.21% |